» Articles » PMID: 33599956

Naringenin Ameliorates Chronic Sleep Deprivation-Induced Pain Via Sirtuin1 Inhibition

Overview
Journal Neurochem Res
Specialties Chemistry
Neurology
Date 2021 Feb 18
PMID 33599956
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Growing experimental evidences have suggested the reciprocal correlation between sleep deprivation and pain. Inflammation and oxidative stress are among the key pathways underlying this correlation. Therefore, the present study was aimed to assess the effect of antioxidant and anti-inflammatory compound naringenin (NGN) against chronic sleep deprivation (CSD)-induced mechanical and thermal hyperalgesia in female Swiss albino mice. In this study, mice were chronically sleep-deprived for 8 h a day for five days a week with the weekend as a free sleep period and continued for nine weeks using a modified multiple platform method. The pain behavioral tests were conducted at the end of the fourth week to assess the development of hyperalgesia followed by the administration of NGN and a combination of NGN with Sirtinol (SIR, a sirtuin1 inhibitor) till the end of the study. After nine weeks, pain behavioral tests, along with oxidative stress and inflammatory parameters in cortex and striatum, were assessed. Results indicated that CSD-induced hyperalgesia in mice accompanied by increased oxidative stress and inflammatory markers in cortex and striatum of the brain. NGN combatted the hyperalgesic response and also decreased levels of oxidative stress and inflammatory markers. Furthermore, the pharmacological effect of NGN was mitigated with SIR. Thus, the findings of the present study reveal that NGN is acting via sirtuin1 to exert its antinociceptive activity against CSD-induced hyperalgesia.

Citing Articles

A Narrative Review of the Reciprocal Relationship Between Sleep Deprivation and Chronic Pain: The Role of Oxidative Stress.

Chen S, Xie Y, Liang Z, Lu Y, Wang J, Xing F J Pain Res. 2024; 17:1785-1792.

PMID: 38799272 PMC: 11122178. DOI: 10.2147/JPR.S455621.


Sirtuins as Players in the Signal Transduction of Flavonoids.

Lombardo G, Russo C, Maugeri A, Navarra M Int J Mol Sci. 2024; 25(4).

PMID: 38396635 PMC: 10889095. DOI: 10.3390/ijms25041956.


Dehydrocorydaline alleviates sleep deprivation-induced persistent postoperative pain in adolescent mice through inhibiting microglial P2Y receptor expression in the spinal cord.

Yang H, Zhang Y, Duan Q, Ni K, Jiao Y, Zhu J Mol Pain. 2023; 19:17448069231216234.

PMID: 37940138 DOI: 10.1177/17448069231216234.


Dietary polyphenols and sleep modulation: Current evidence and perspectives.

Perez-Jimenez J, Agnant K, Lamuela-Raventos R, St-Onge M Sleep Med Rev. 2023; 72:101844.

PMID: 37659249 PMC: 10872761. DOI: 10.1016/j.smrv.2023.101844.


S-Ketamine Pretreatment Alleviates Anxiety-Like Behaviors and Mechanical Allodynia and Blocks the Pro-inflammatory Response in Striatum and Periaqueductal Gray From a Post-traumatic Stress Disorder Model.

Yang S, Xu K, Xu X, Zhu J, Jin Y, Liu Q Front Behav Neurosci. 2022; 16:848232.

PMID: 35493953 PMC: 9047507. DOI: 10.3389/fnbeh.2022.848232.

References
1.
Schuh-Hofer S, Wodarski R, Pfau D, Caspani O, Magerl W, Kennedy J . One night of total sleep deprivation promotes a state of generalized hyperalgesia: a surrogate pain model to study the relationship of insomnia and pain. Pain. 2013; 154(9):1613-1621. DOI: 10.1016/j.pain.2013.04.046. View

2.
Schrimpf M, Liegl G, Boeckle M, Leitner A, Geisler P, Pieh C . The effect of sleep deprivation on pain perception in healthy subjects: a meta-analysis. Sleep Med. 2015; 16(11):1313-1320. DOI: 10.1016/j.sleep.2015.07.022. View

3.
Araujo P, Mazaro-Costa R, Tufik S, Andersen M . Impact of sex on hyperalgesia induced by sleep loss. Horm Behav. 2010; 59(1):174-9. DOI: 10.1016/j.yhbeh.2010.11.003. View

4.
Jansson-Frojmark M, Boersma K . Bidirectionality between pain and insomnia symptoms: a prospective study. Br J Health Psychol. 2011; 17(2):420-31. DOI: 10.1111/j.2044-8287.2011.02045.x. View

5.
Ji R, Xu Z, Gao Y . Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov. 2014; 13(7):533-48. PMC: 4228377. DOI: 10.1038/nrd4334. View